Document is current
Any future updates will be listed below
-
Authors
Mamiya, Yukiyo
Taida, Takashi
Kato, Jun
Matsusaka, Keisuke
Matsubara, Yoshiki
Ozaki, Tomomi
Ohashi, Takuya
Ito, Toshiyuki
Mukai, Syohei
Syu, Nobuaki
Koshibu, Yushi
Ozeki, Yusuke
Furuya, Makoto
Oyama, Yuhei
Nakazawa, Hayato
Horio, Ryosuke
Goto, Chihiro
Takahashi, Satsuki
Ozawa, Yoshihito
Shiko, Yuki
Kurosugi, Akane
Sonoda, Michiko
Kaneko, Tatsuya
Ishikawa, Tsubasa
Ohta, Yuki
Okimoto, Kenichiro
Saito, Keiko
Matsumura, Tomoaki
Ikeda, Jun-ichiro
Kato, Naoya
- License Information
-
More Information
Article History
Received: 30 November 2024
Accepted: 2 January 2025
First Online: 27 January 2025
Declarations
:
: Takashi Taida received research grants from AbbVie G.K.. Jun Kato received honoraria from Eisai Co., Ltd., Takeda Pharmaceutical Co., Ltd., Abbvie G.K., Zeria Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Corporation, and JIMRO Co., Ltd., Mochida Pharmaceutical Co., Ltd.. Naoya Kato received honoraria from AbbVie G.K., Ohtsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Zeria Pharmaceutical Co., Ltd., Olympus Corporation, Eisai Co., Ltd., Tsumura & Co., Mochida Pharmaceutical Co., Ltd., Miyarisan Pharmaceutical Co., Ltd., Yakult Honsha Co., Ltd., Olympus Marketing, Inc., and Janssen Pharmaceutical K.K., and research funding from Ohtsuka Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Eisai Co., Ltd., Tsumura & Co., Nippon Kayaku Co., Ltd., and JIMRO Co., Ltd.. The other authors have no conflicts of interest to declare.
